Majzner and colleagues show that engineering T cells with a membrane-tethered version of the signaling adaptor molecule SLP-76 alongside a chimeric antigen receptor (CAR) enhances CAR T cell activity against low-antigen-density tumors.
- Maria Caterina Rotiroti
- Aidan M. Tousley
- Robbie G. Majzner